025620.KS
CHA AI Healthkare
KSC · Consumer Cyclical · Household & Personal Products · KR
KRW 4,705.00
−1.57%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 8.4B | 7.3B | 15.7B | 16.1B | 6.2B |
| Cost of Revenue | 6.7B | 6.0B | 8.3B | 8.1B | 5.3B |
| Gross Profit | 1.7B | 1.3B | 7.4B | 8.0B | 904.5M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 6.4B | 5.2B | 10.9B | 17.3B | 8.2B |
| General & Admin Expense | 1.6B | 926.1M | 1.1B | 5.8B | 3.3B |
| Selling & Marketing Expense | 4.8B | 4.3B | 9.8B | 11.5B | 4.9B |
| Other Expenses | 3.4B | 3.8B | 1.9B | (665.3M) | 663.3M |
| Total Operating Expenses | 9.8B | 9.0B | 12.8B | 16.6B | 8.9B |
| Cost and Expenses | 16.4B | 15.0B | 21.1B | 24.7B | 14.2B |
| Operating Income (EBIT) | (7.8B) | (7.7B) | (5.4B) | (10.2B) | (8.0B) |
| Non-Operating | |||||
| Interest Income | 944.9M | 834.4M | 832.3M | 397.7M | 198.6M |
| Interest Expense | 3.1B | 1.1B | 122.9M | 128.8M | 484.8M |
| Net Interest Income | (2.2B) | (249.0M) | 709.4M | 268.9M | (286.2M) |
| Other Non-Op Income/Expense | 16.0B | 9.1B | (2.8B) | 3.4B | (11.5B) |
| Non-Operating Income (excl Interest) | (7.8B) | — | 2.7B | (580.3M) | 11.0B |
| EBT (Pre-Tax Income) | 8.2B | 1.4B | (8.3B) | (6.8B) | (19.5B) |
| Income Tax Expense | (140.00) | — | 1.5B | 10.2M | 9.4B |
| Bottom Line | |||||
| Net Income | 8.1B | 1.4B | (9.5B) | (6.8B) | (21.4B) |
| Earnings from Cont. Ops | 8.2B | 1.4B | (9.8B) | (6.0B) | (19.5B) |
| Earnings from Discont. Ops | — | — | 308.5M | (830.5M) | (2.2B) |
| Bottom Line Net Income | 9.3B | 1.4B | (9.5B) | (6.8B) | (21.4B) |
| Per Share | |||||
| Basic EPS | ₩295 | ₩181 | (₩2,123) | (₩1,560) | (₩7,588) |
| Diluted EPS | ₩220 | ₩181 | (₩2,123) | (₩1,560) | (₩7,588) |
| Revenue Per Share | ₩464 | ₩401 | ₩3,504 | ₩3,693 | ₩2,211 |
| Shares | |||||
| Basic Shares Outstanding | 18.2M | 18.2M | 4.5M | 4.4M | 2.8M |
| Diluted Shares Outstanding | 23.2M | 18.2M | 4.5M | 4.4M | 2.8M |
| Profitability Metrics | |||||
| EBITDA | (7.1B) | (6.9B) | (7.6B) | (8.9B) | (18.4B) |
| D&A | 848.6M | 755.0M | 567.2M | 671.1M | 580.2M |
| EBIT | (8.0B) | (7.7B) | (8.2B) | (9.6B) | (8.0B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026